Method Validation in Clinical Laboratories: A Practical Protocol

Method validation is the process of establishing that a diagnostic test performs reliably for its intended clinical use before patient results are reported. This protocol applies to laboratory professionals who need a practical, step-by-step approach to validating new testing methods, whether the method is developed in-house, modified from a manufacturer's procedure, or transferred from another facility. The distinction between verification and validation matters at the outset. Verification is a one-time process to confirm that a marketed test system performs as claimed before it is used for patient testing. Validation establishes the performance of a new diagnostic tool such as an internally developed or modified method. Consumers of marketed test kits should verify method accuracy, precision, analytic measurement range, and the appropriateness of reference intervals to the institution's patient population, while more extensive validation may be required for new methods and those manufacturer methods that have been modified by the laboratory, including analytic sensitivity and specificity 6.

At a Glance

The table below summarizes the core validation parameters, the practical question each parameter answers, and the minimum evidence a laboratory should collect before reporting patient results.

Scope and Regulatory Context

Clinical laboratories operate under a layered set of expectations from international quality standards, accreditation bodies, and regional regulations. The International Organization for Standardization, the Clinical Laboratory Standards Institute, the College of American Pathologists, the Joint Commission, the U.K. Clinical Pathology Accreditation, and the Clinical Laboratory Improvement Amendments of 1988 all describe requirements for method verification and validation 6. The World Health Organization Laboratory Quality Management System Handbook provides a framework for building quality systems that support reliable testing 1. A laboratory that validates methods properly maintains accreditation scope and can continue offering clinically important analytes even when regulatory changes affect the status of commercial reagents 7.

The European regulation on in vitro diagnostic medical devices has caused some laboratory determinations to lose their CE marking. In one example, Krebs von den Lungen-6, a diagnostic and prognostic marker for interstitial lung disease, carried research use only marking, and the laboratory validated the method with the new reagent to continue clinical care of patients and keep the analyte within the scope of accreditation 7. This scenario illustrates a common driver for validation work. Laboratories do not validate methods only when developing something new. They also validate when reagent sources change, when instrumentation is replaced, or when regulatory status of a commercial product shifts.

Core Principles of Method Validation

Fit-for-Purpose Validation

The fit-for-purpose approach selects validation parameters based on the intended use of the assay. Analytical method validation provides a means to ensure that data are credible and reproducible 5. A research laboratory validating a flow cytometry panel for exploratory work needs less evidence than a clinical laboratory validating a moderate-risk laboratory developed test. The validation plan should match the risk of the clinical decision the test supports. Four types of validation protocols illustrate this principle. The limited validation protocol is recommended for research and non-regulated laboratories. A fit-for-purpose validation approach is appropriate for biopharma and research settings. A third type addresses validation performed in clinical laboratories for moderate-risk tests developed in house. A fourth describes the process applied when a method is transferred from one facility to another 5. These protocols represent minimal requirements and may not apply to high-risk clinical assays or data used as a primary endpoint in a clinical trial 5.

Verification versus Validation

Method verification and method validation are frequently confused. Verification is a one-time process to determine performance characteristics before a test system is utilized for patient testing. Validation establishes the performance of a new diagnostic tool such as an internally developed or modified method 6. The practical difference is straightforward. If you purchase a cleared or approved test from a manufacturer and use it exactly as instructed, you verify its performance in your laboratory. If you develop a test yourself, modify a manufacturer's method, or use a research use only reagent for clinical care, you validate it. The evidence burden for validation is heavier because no manufacturer has already established performance characteristics for your specific configuration.

Validation Parameters

The core parameters for any validation study include precision, accuracy, linearity, and reference interval verification. Additional parameters such as analytic sensitivity, analytic specificity, limit of blank, and limit of detection may be required for new methods or modified manufacturer methods 6. The Clinical Laboratory Standards Institute evaluation protocols provide guidance for performing method verification experiments 6. Specific protocols such as EP5, EP6, EP7, EP9, EP15, and EP28 are commonly cited in validation studies 10. A laboratory validating a direct assay for exchangeable copper by inductively coupled plasma-mass spectrometry followed these CLSI protocols and demonstrated excellent linearity, precision with coefficient of variation below six percent, and inter-laboratory reproducibility 10.

Practical Workflow for Method Validation

Step 1: Define the Intended Use

Write a clear statement of what the method will measure, in what sample type, for what clinical purpose, and in which patient population. This statement drives every subsequent decision about which validation parameters to include and what performance criteria to set. A method intended to guide urgent treatment decisions requires tighter precision and accuracy targets than a method used for chronic disease monitoring. The intended use statement also determines whether you need to validate the method for a specific matrix such as serum, plasma, urine, or whole blood.

Step 2: Select Validation Parameters

Choose parameters based on the intended use and risk level. For a moderate-risk laboratory developed test, include precision, accuracy, linearity, limit of blank, limit of detection, and reference interval verification. For a method transferred from another facility, confirm that the method performs equivalently in your hands. The fit-for-purpose approach means you select validation parameters based on the intended use of the assay 5. Document the rationale for each parameter you include and each parameter you exclude.

Step 3: Design the Experiment

Determine the number of samples, replicates, runs, and days needed to achieve statistically meaningful results. Precision studies should include multiple runs across several days to capture between-run and between-day variability. Linearity studies require a dilution series that spans the full measuring interval. Accuracy studies require a comparison method or reference material with known values. The sample size should be sufficient to detect clinically meaningful deviations from expected performance.

Step 4: Collect Data

Use a standardized data collection template that records the sample identifier, replicate number, run number, date, operator, instrument, reagent lot, and result. Record any unusual observations such as instrument alarms, reagent preparation issues, or sample quality problems. These records support troubleshooting if validation fails and provide evidence for accreditation reviewers.

Step 5: Analyze Results

Calculate precision as coefficient of variation, assess linearity by evaluating recovery across the dilution series, and compare accuracy results against the reference method or known values. Evaluate reference intervals using transference validation criteria. If results meet your pre-defined acceptance criteria, document the validation as successful. If results fail, investigate the cause, correct the issue, and repeat the affected experiments.

Step 6: Document and Approve

Prepare a validation report that includes the intended use statement, experimental design, raw data summary, statistical analysis, acceptance criteria, results, and conclusions. The report should be reviewed and approved by the laboratory director or designated quality representative before the method is used for patient testing. Retain the report and supporting data for accreditation and regulatory review.

Precision Studies

Precision is the closeness of agreement between independent test results obtained under stipulated conditions. It is expressed as standard deviation or coefficient of variation. Precision has multiple components. Repeatability is precision under the same operating conditions over a short time interval. Reproducibility is precision under different conditions such as different operators, instruments, or days. A validation study should assess both within-run and between-run precision.

The practical design for a precision study uses at least two levels of analyte concentration, typically a low level near the clinical decision point and a high level near the upper limit of the measuring interval. Each level is measured in replicate across multiple runs and days. The resulting data allow calculation of within-run, between-run, and total precision. The acceptance criteria should be defined before the study begins and should be based on the clinical use of the method. A method used to monitor a critical analyte with a narrow therapeutic range requires tighter precision than a method used for a screening test with a wide diagnostic window.

In the validation of a pooled antibiotic susceptibility testing method, precision above 95 percent was required across all analysis groups 11. This example shows that precision targets vary by method type and clinical application. For a quantitative chemistry method, coefficient of variation targets are typically set based on biological variation of the analyte. For a qualitative method such as susceptibility testing, precision is expressed as percent agreement between replicate results.

Accuracy and Method Comparison

Accuracy is the closeness of agreement between the measured value and the true value. Accuracy can be assessed by analyzing certified reference materials, by comparing results to a reference method, or by spiking known amounts of analyte into a sample matrix. Method comparison studies evaluate the agreement between the new method and an established method using patient samples that span the measuring interval.

The Clinical Laboratory Standards Institute EP9 protocol guides method comparison experiments 10. The comparison should include samples across the full measuring interval, with particular attention to concentrations near clinical decision points. Data are analyzed using regression statistics and bias calculations. Bland-Altman plots provide a visual assessment of agreement across the measuring range and help identify concentration-dependent bias 10.

For qualitative methods such as antibiotic susceptibility testing, accuracy is expressed as categorical agreement, very major errors, major errors, and minor errors. The CLSI target performance criteria include at least 90 percent categorical agreement, less than 3 percent very major errors, less than 3 percent major errors, and minor errors at or below 10 percent 11. In a full validation of pooled antibiotic susceptibility testing, the method met these targets across five groups of uropathogenic organisms for up to 20 antibiotics per group 11. The study included fresh and frozen clinical urine specimens as well as contrived specimens from pre-characterized challenge isolates 11.

Linearity and Measuring Interval

Linearity is the ability of a method to produce results directly proportional to the concentration of the analyte in the sample. The measuring interval is the range of concentrations over which the method produces reliable results without dilution or concentration. Linearity studies use a series of samples with known relative concentrations, typically prepared by diluting a high-concentration sample with a low-concentration sample or diluent.

The dilution series should span the full measuring interval claimed by the manufacturer or established during method development. Each level is measured in replicate, and the observed results are compared to the expected values. Recovery is calculated as the observed value divided by the expected value, expressed as a percentage. Acceptable recovery is typically within a defined range such as 90 to 110 percent, though the specific criteria depend on the method and clinical use.

A validation study of the KL6 method on the G600II analyzer followed CLSI protocols for precision, linearity, limit of blank, and limit of detection, obtaining results within the limits established by the laboratory 7. This example demonstrates that linearity studies are a routine component of clinical method validation. The limit of blank is the highest apparent analyte concentration expected when a blank sample is measured. The limit of detection is the lowest analyte concentration that can be reliably distinguished from the blank. Both parameters are particularly important for methods used to detect low concentrations of analytes.

Reference Interval Verification

Reference intervals provided by diagnostic test manufacturers should be transferred to clinical laboratories after validation 8. Although protocols exist, laboratories rarely perform and report on results of validation studies 8. This gap in practice is a common finding in laboratory quality audits.

A study validating reference intervals of 87 analytes on a Cobas 8000 platform according to CLSI standards found that 8 of 79 reference intervals subjected to transference validation were not valid for transference 8. The analytes with invalid reference intervals included lactate dehydrogenase among women and potassium, homocysteine, immunoglobulin E, free lambda light chain, C3 complement, folate, and 25-hydroxy vitamin D among both sexes 8. For some of these analytes, suitable reference intervals were available in the literature, but for immunoglobulin E and free lambda light chain, no suitable alternatives were found 8. This study demonstrates that validation of reference intervals provided in manufacturer package inserts is indispensable 8.

The practical approach to reference interval verification depends on the number of samples available. A full reference interval study requires a large number of healthy volunteers, typically 120 or more per partition. A transference study uses a smaller number of samples, typically 20 per partition, to confirm that the manufacturer's reference interval applies to the laboratory's patient population. If the transference study fails, the laboratory must either establish its own reference interval or find a suitable interval from the literature.

Limit of Blank and Limit of Detection

The limit of blank is the highest measurement result expected when replicates of a blank sample are measured. The limit of detection is the lowest analyte concentration that can be distinguished from the blank with a defined level of confidence. Both parameters are essential for methods used to detect low concentrations of analytes, such as tumor markers, cardiac biomarkers, or drugs of abuse.

The limit of blank is determined by measuring a blank sample multiple times and calculating the mean plus a multiple of the standard deviation. The limit of detection is determined by measuring samples with known low concentrations and identifying the concentration that can be reliably distinguished from the blank. The limit of quantitation is the lowest concentration at which the method can measure the analyte with acceptable precision and accuracy.

In the validation of the KL6 method, the laboratory studied limit of blank and limit of detection following CLSI protocols 7. These parameters are particularly important when a method is used to detect early disease or minimal residual disease, where the clinical question is whether the analyte is present at all.

Validation of Laboratory Developed Tests

Laboratory developed tests require more extensive validation than manufacturer methods used as instructed. The additional parameters include analytic sensitivity and specificity 6. Analytic sensitivity is the ability of the method to detect small quantities of the analyte. Analytic specificity is the ability of the method to measure only the intended analyte without interference from other substances in the sample.

For immunohistochemistry assays, different clones, protocol conditions, instruments, and scoring methods may pose challenges in introducing different assays for clinical use 12. When a testing laboratory is not able to use an FDA-approved companion diagnostic for its specific clinical purpose, it is better to develop a properly validated laboratory developed test for the same purpose as the original FDA-approved immunohistochemistry assay 12. This recommendation reflects the reality that assay interchangeability cannot be assumed without validation evidence.

The validation of a direct assay for exchangeable copper by inductively coupled plasma-mass spectrometry illustrates the scope of a laboratory developed test validation 10. The study followed CLSI protocols EP5, EP6, EP7, EP9, EP15, and EP28 and demonstrated excellent linearity, precision with coefficient of variation below six percent, and inter-laboratory reproducibility 10. The validated assay overcame the limitations of the traditional non-ceruloplasmin-bound copper calculation, which is indirect and analytically imprecise 10.

Transfer Validation

Transfer validation applies when a method is moved from one facility to another 5. The goal is to confirm that the method performs equivalently in the receiving laboratory. Transfer validation is common in multi-site laboratory networks, when a laboratory adopts a method developed at another institution, or when testing is moved between facilities.

The transfer validation protocol should include the same parameters as the original validation, though the extent of testing may be reduced if the method is well characterized. The receiving laboratory should assess precision, accuracy, and reference interval applicability. If the method will be used for a different patient population than the originating laboratory, reference interval verification is essential.

Data Collection Template

A standardized data collection template supports consistent and complete validation records. The template should include the following fields for each measurement:

The template should be designed before the validation study begins and should be used consistently throughout. Electronic data capture with automated calculations reduces transcription errors and supports statistical analysis. Paper templates should include clear instructions for completing each field and should be reviewed for completeness before the validation report is prepared.

Common Failure Patterns

Insufficient Number of Replicates

A common failure in validation studies is collecting too few replicates to support statistically meaningful conclusions. Precision estimates based on a small number of measurements have wide confidence intervals and may not reflect true method performance. The number of replicates should be determined before the study begins based on the expected variability of the method and the desired confidence in the results.

Incomplete Measuring Interval Coverage

Linearity and accuracy studies that do not span the full measuring interval may miss nonlinearity or bias at the extremes of the range. Samples should be selected to cover the entire clinically relevant range, including concentrations near the lower and upper limits. Gaps in coverage can hide problems that only appear at high or low concentrations.

Inappropriate Reference Interval Transference

Reference intervals from the manufacturer or from the literature may not apply to the laboratory's patient population. Age, sex, ethnicity, and geographic factors can affect reference values. A transference study using samples from the local population is essential before reporting reference intervals for patient care.

Failure to Document Deviations

Validation studies rarely proceed exactly as planned. Instrument failures, reagent problems, and operator errors occur. Failure to document these deviations makes it difficult to interpret results and to defend the validation during accreditation review. Every deviation should be recorded with a description of the issue, the corrective action taken, and the impact on the validation data.

Confusing Verification with Validation

Using a marketed test system exactly as instructed requires verification, not full validation. Laboratories that perform full validation for unmodified manufacturer methods waste resources. Laboratories that skip validation for modified methods or laboratory developed tests risk reporting unreliable results. The distinction between verification and validation should be clear in the laboratory's quality documents 6.

Quality Controls and Ongoing Monitoring

Method validation establishes that a method performs acceptably at a point in time. Ongoing quality control ensures that the method continues to perform acceptably during routine use. Quality control materials should be analyzed at defined intervals, typically with each run or each day of testing. Control results should be evaluated against pre-defined acceptance criteria using statistical rules that detect shifts and trends.

The World Health Organization Laboratory Quality Management System Handbook provides guidance on building quality systems that support reliable testing 1. A robust quality system includes documented procedures, trained personnel, calibrated instruments, and a process for investigating quality control failures. When quality control results exceed acceptance criteria, patient results from the affected runs should not be reported until the problem is resolved.

Proficiency testing provides an external check on method performance. Participation in proficiency testing programs allows the laboratory to compare its results with those of other laboratories using the same or similar methods. Poor proficiency testing performance may indicate a method problem that requires investigation and possibly revalidation.

Biosafety Considerations

Method validation often involves handling biological samples that may contain infectious agents. The World Health Organization Laboratory Biosafety Manual provides guidance on safe handling of biological materials 2. Validation studies should follow the same biosafety practices as routine testing, including appropriate personal protective equipment, containment procedures, and waste disposal.

Validation of methods for new sample types or new analytes may introduce new biosafety risks. For example, a method that requires sample concentration or extraction may generate aerosols that increase exposure risk. The validation protocol should include a biosafety assessment that identifies potential hazards and specifies controls. Personnel performing validation studies should receive training on the specific hazards associated with the samples and procedures.

Professional Escalation Criteria

Laboratory professionals should escalate validation issues to the laboratory director or quality manager when certain conditions are met. Escalation is appropriate when validation results fail to meet acceptance criteria after troubleshooting, when a method demonstrates clinically significant bias or imprecision, when reference intervals cannot be verified for the local population, or when regulatory changes affect the status of a commercial reagent used for patient testing.

The validation of KL6 after the reagent lost CE marking illustrates a situation where escalation to laboratory leadership was necessary to decide whether to continue offering the test and how to maintain accreditation scope 7. Similarly, when reference interval transference fails for an analyte with no suitable alternative interval in the literature, the laboratory director must decide whether to establish a new reference interval or discontinue the test 8.

Escalation should be documented in the validation records, including the reason for escalation, the individuals involved, the decision made, and the rationale for the decision. This documentation supports transparency and defensibility during accreditation review.

Limitations of Method Validation

Method validation has inherent limitations that laboratory professionals should understand. Validation studies use a finite number of samples and may not capture all sources of variability that occur during routine use. Interference from substances not tested during validation may appear when the method is applied to a broader patient population. The fit-for-purpose approach means that a validation that is adequate for one intended use may not be adequate for another 5.

Validation does not guarantee that a method will perform acceptably forever. Changes in reagent lots, instrument components, operator technique, or sample matrix can affect method performance. Ongoing quality control and periodic verification of performance characteristics are necessary to detect changes over time.

The FDA and EMA guidance documents on bioanalytical method validation are similar but not identical 19. The EMA describes the practical conduct of experiments more precisely, while the FDA presents reporting recommendations more comprehensively 19. There are also differences in recommended validation parameters 19. Laboratories that operate under multiple regulatory frameworks must be aware of these differences and may need to comply with more than one set of requirements 19. The FDA guidance on bioanalytical method validation provides the current regulatory expectations for bioanalytical methods used to support drug development 3.

Frequently Asked Questions

What is the difference between method verification and method validation?

Method verification is a one-time process to determine performance characteristics before a test system is utilized for patient testing. Method validation establishes the performance of a new diagnostic tool such as an internally developed or modified method 6. Consumers of marketed test kits should verify method accuracy, precision, analytic measurement range, and the appropriateness of reference intervals to the institution's patient population 6. More extensive validation may be required for new methods and those manufacturer methods that have been modified by the laboratory 6.

Which validation parameters should I include in my study?

The fit-for-purpose approach selects validation parameters based on the intended use of the assay 5. Core parameters include precision, accuracy, linearity, and reference interval verification. Additional parameters such as analytic sensitivity and specificity may be required for new methods and modified manufacturer methods 6. Limit of blank and limit of detection are important for methods used to detect low concentrations of analytes 7.

How many samples do I need for a validation study?

The number of samples depends on the parameter being evaluated and the statistical confidence required. Precision studies need enough replicates to estimate within-run and between-run variability. Linearity studies need a dilution series spanning the full measuring interval. Reference interval transference studies typically use a smaller number of samples than full reference interval studies. The sample size should be sufficient to detect clinically meaningful deviations from expected performance.

What should I do if my validation results fail to meet acceptance criteria?

Investigate the cause of the failure before repeating experiments. Check instrument function, reagent preparation, sample quality, and operator technique. Document the investigation and corrective actions. If the failure persists, escalate to the laboratory director or quality manager. Do not report patient results until the method meets acceptance criteria.

How do I validate a method transferred from another facility?

Transfer validation confirms that the method performs equivalently in the receiving laboratory 5. The transfer protocol should include the same parameters as the original validation, though the extent of testing may be reduced if the method is well characterized. Assess precision, accuracy, and reference interval applicability. If the method will be used for a different patient population, reference interval verification is essential.

What is the role of CLSI protocols in method validation?

The Clinical Laboratory Standards Institute evaluation protocols provide guidance for performing method verification experiments 6. Specific protocols such as EP5, EP6, EP7, EP9, EP15, and EP28 are commonly cited in validation studies 10. These protocols describe experimental designs and statistical analyses for evaluating precision, linearity, interference, method comparison, and reference intervals.

When should I validate a reference interval from a manufacturer?

Reference intervals provided by diagnostic test manufacturers should be transferred to clinical laboratories after validation 8. A study validating reference intervals of 87 analytes found that 8 of 79 reference intervals subjected to transference validation were not valid for transference 8. This demonstrates that validation of reference intervals provided in manufacturer package inserts is indispensable 8.

What documentation should I keep from a validation study?

Keep the validation protocol, raw data, statistical analysis, acceptance criteria, results, and conclusions in a validation report. Include the intended use statement, experimental design, and any deviations from the protocol. Retain the report and supporting data for accreditation and regulatory review. Document any escalations and decisions made during the validation process.

Related Diagnostic Guides

• Laboratory Results Template: How to Present Data Clearly and Reproducibly
• How to Perform a Gravimetric Pipette Calibration: Protocol and Data Recording
• Laboratory Measurements: Units, Accuracy, and Significant Figures in Experimental Data
• Multiplex Real-Time RT-PCR for Differential Diagnosis of Canine Infectious Respiratory Disease Complex (CIRDC): Panel Design, Validation, and Clinical Utility
• Laboratory Observation: Recording and Reporting Experimental Findings

References and Further Reading

• Laboratory Quality Management System Handbook. World Health Organization.
• Laboratory Biosafety Manual. World Health Organization.
• Bioanalytical Method Validation Guidance. U.S. Food and Drug Administration.
• NCBI Literature Resources. National Center for Biotechnology Information.
• Flow Cytometry Method Validation Protocols.. Current protocols, 2023.
• Verification of method performance for clinical laboratories.. Advances in clinical chemistry, 2009.
• Validation of the KL6 Method on the G600II Analyser (Lumipulse) for Clinical Use in Interstitial Lung Disease.. EJIFCC, 2024.
• CLSI-Based Validation of Manufacturer-Derived Reference Intervals on the Cobas 8000 Platform.. Laboratory medicine, 2017.
• A Simplified Perchloric Acid Workflow With Neutralization (PCA N) for Democratizing Deep Plasma Proteomics at Population Scale.. Molecular & cellular proteomics : MCP, 2025.
• CLSI Validation of Exchangeable Copper Determination in Serum by ICP-MS: A Focus on Alzheimer's Disease and Wilson Disease.. Biomolecules, 2025.
• Full Validation of Pooled Antibiotic Susceptibility Testing Using CLSI Methods and Performance Criteria in UTI Pathogens.. Antibiotics (Basel, Switzerland), 2025.
• "Interchangeability" of PD-L1 immunohistochemistry assays: a meta-analysis of diagnostic accuracy.. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 2020.
• Microwave-assisted hydrolysis and HPAEC-PAD for simultaneous quantification of sialic acid and six other glycan monosaccharides in human serum: RSM optimization, validation, and proof-of-concept application to acute stroke.. 2026.
• Fabrication of Fe-Mn mixed oxide nanosheets via microwave assistance as an advanced probe for ultra-sensitive nepafenac sensing in diverse matrices, paving the way for future applications.. 2026.
• Comparing conventional correction formulas and machine learning-based prediction of ionized calcium.. 2026.
• Development and validation of a green DLLME-LC-MS/MS method for apixaban quantification in human plasma using Box-Behnken design optimization with application to pharmacokinetic studies and sustainability assessment.. 2026.
• Green HPLC-PDA method for simultaneous determination of linagliptin and cefixime with pharmacokinetic application in rats.. 2026.
• Where do you draw the line? Points to consider when implementing the FDA method validation guidance on quantifying chromatographic peaks. 2002.
• Bioanalytical method validation: new FDA guidance vs. EMA guideline. Better or worse?. Journal of Pharmaceutical and Biomedical Analysis, 2019.
• Workshop Report: Crystal City V-Quantitative Bioanalytical Method Validation and Implementation: The 2013 Revised FDA Guidance. AAPS Journal, 2015.
• CONTEST: A generalization of ONEST to estimate sample size for predictive augmented intelligence method validation studies. Journal of Pathology Informatics, 2025.
• STRUCTURE OF CHEMICAL COMPOUNDS, METHODS OF ANALYSIS AND PROCESS CONTROL COMPARISON OF FDA (2018) AND EAEU REGULATORY REQUIREMENTS FOR BIOANALYTICAL METHOD VALIDATION. 2019.

This article is educational and does not replace validated laboratory procedures, institutional biosafety review, manufacturer instructions, or professional interpretation.